- Home
- RLAY vs ELVR Comparison
RLAY vs ELVR Comparison
Compare RLAY & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLAY | ELVR |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLAY | ELVR |
|---|---|---|
| Price | $9.15 | $55.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $15.75 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 96.6K |
| Earning Date | 02-24-2026 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $8,355,000.00 | ★ $146,440,045.00 |
| Revenue This Year | $19.96 | $22.93 |
| Revenue Next Year | N/A | $7.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.20 |
| 52 Week Low | $1.78 | $15.55 |
| 52 Week High | $9.25 | $69.99 |
Technical Indicators
Market Signals| Indicator | RLAY | ELVR |
|---|---|---|
| Relative Strength Index (RSI) | 59.52 | 53.18 |
| Support Level | $8.08 | $45.12 |
| Resistance Level | $9.25 | $49.31 |
| Average True Range (ATR) | 0.67 | 2.79 |
| MACD | 0.12 | -0.61 |
| Stochastic Oscillator | 83.02 | 46.91 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About ELVR Sayona Mining Limited American Depository Shares
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is the identification, acquisition, and evaluation of mineral exploration assets, focusing on lithium. The projects of the company include the Moblan Lithium Project, the Carolina Lithium Project, the Ewoyaa Lithium Project, North American Lithium, and other projects. The company also holds an interest in a tenement portfolio in the Pilbara region, prospective for gold and lithium.